Trial Profile
Actinic Keratoses and 5% Topical Imiquimod: Lessons to Learn From a Prospective Non-Interventional Study by 93 Office-based Dermatologists.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2010
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 06 Jul 2010 New trial record